This page lists the SEC filings reported by BioNTech SE.
Type | Filed | |
---|---|---|
6-K | 2024-05-21 | EDGAR |
6-K | 2024-05-17 | EDGAR |
6-K | 2024-05-06 | EDGAR |
6-K | 2024-05-06 | EDGAR |
6-K | 2024-04-08 | EDGAR |
6-K | 2024-04-08 | EDGAR |
6-K | 2024-03-25 | EDGAR |
20-F | 2024-03-20 | EDGAR |
6-K | 2024-03-20 | EDGAR |
6-K | 2024-03-20 | EDGAR |
6-K | 2024-03-11 | EDGAR |
6-K | 2024-03-07 | EDGAR |
144 | 2024-02-28 | EDGAR |
SC 13D | 2024-02-21 | EDGAR |
S-8 | 2024-02-15 | EDGAR |
SC 13G/A | 2024-02-14 | EDGAR |
6-K | 2024-02-08 | EDGAR |
SC 13G/A | 2024-02-07 | EDGAR |
6-K | 2024-01-31 | EDGAR |
6-K | 2024-01-22 | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.